Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	45.79B
Revenue (ttm)	4.55B
Net Income (ttm)	1.65B
Shares Out	785.72M
EPS (ttm)	2.10
PE Ratio	27.76
Forward PE	25.18
Dividend	1.30 (2.23%)
Ex-Dividend Date	May 28, 2025

Volume	3,238,040
Average Volume	2,678,107
Open	58.57
Previous Close	58.36
Day's Range	57.33 - 58.75
52-Week Range	49.01 - 72.90
Beta	-0.34
RSI	35.55
Earnings Date	Apr 17, 2026

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,841
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.